45 / 78
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 28, No 6, November/December 2017
AFRICA
383
surveillance. The WHO STEPwise approach to surveillance of noncom-
municable diseases (STEPS ). 2003. www.who.int/...surveillance/.../
steps_framework_dec03.pdf.
13. Eknoyan G. Adolphe Quetelet (1796–1874) . The average man and
indices of obesity.
Nephrol Dial Transpl
2008;
23
(1): 47–51. doi: 10.1093/
ndt/gfm517.
14. Levey AS, Stevens LA, Schmid CH,
et al
. A new equation to estimate
glomerular filtration rate.
Ann Intern Med
2009;
150
(9): 604–612. doi:
10.7326/0003-4819-150-9-200905050-00006.
15. Mancia G, Fagard R, Narkiewicz K,
et al
. 2013 ESH/ESC guidelines for
the management of arterial hypertension: the task force for the manage-
ment of arterial hypertension of the European Society of Hypertension
(ESH) and of the European Society of Cardiology (ESC).
Eur Heart J
2013;
34
(28): 2159–2219. doi: 10.1093/eurheartj/eht151.
16. World Health Organization. Definition and diagnosis of diabetes melli-
tus and intermediate hyperglycemia:Report of a WHO/IDF consulta-
tion.
Production
2006: 1–52. doi: ISBN 92 4 159493 4.
17. National Cholesterol Education Program (NCEP) expert Panel.
Third report of the National Cholesterol Education Program (NCEP)
Expert Panel on Detection, Evaluation and Treatment of High Blood
Cholesterol in Adults (Adult Treatment Panel III).
Arch Intern Med
2002;
6
: 284. doi: 10.1001/archinte.1991.00400060019005.
18. Of OJOS, Kidney Disease: Improving Global Outcomes (KDIGO)
CKD work group. KDIGO 2012 Clinical Practice Guideline for the
Evaluation and Management of Chronic Kidney Disease.
Kidney Int
Suppl
2013;
3
(1): 5–14. doi: 10.1038/kisup.2012.76.
19. Dhungana R, Devkota S, Khanal MK,
et al
. Prevalence of cardi-
ovascular health risk behaviors in a remote rural community of
Sindhuli district, Nepal.
BMC Cardiovasc Disord
2014;
14
(1): 92. doi:
10.1186/1471-2261-14-92.
20. Zaman MM, Rahman MM, Rahman MR, Bhuiyan MR, Karim MN,
Chowdhury MAJ. Prevalence of risk factors for non-communicable
diseases in Bangladesh: Results from STEPS survey 2010.
Indian J
Public Health
2016;
60
(1): 17–25. doi: 10.4103/0019-557X.177290.
21. Okpechi IG, Chukwuonye II, Tiffin N,
et al
. Blood pressure gradients
and cardiovascular risk factors in urban and rural populations in Abia
State south eastern Nigeria using the WHO STEPwise approach.
PLoS
One
2013;
8
(9): 4–6. doi: 10.1371/journal.pone.0073403.
22. Lachat C, Otchere S, Roberfroid D,
et al
. Diet and physical activity
for the prevention of noncommunicable diseases in low- and middle-
income countries: a systematic policy review.
PLoS Med
2013;
10
(6).
doi: 10.1371/journal.pmed.1001465.
23. Iwuala SO, Sekoni AO, Olamoyegun MA, Akanbi MA, Sabir AA,
Ayankogbe OO. Self-reported physical activity among health care profes-
sionals in south and west Nigeria.
Niger J Clin Pract
2015;
18
(6): 790–795.
24. Baragou S, Djibril M, Atta B, Damorou F, Pio M, Balogou A.
Prevalence of cardiovascular risk factors in an urban area of Togo: a
WHO STEPS-wise approach in Lome, Togo.
Cardiovasc J Afr
2012;
23
(6): 309–312. doi: 10.5830/CVJA-2011-071.
25. Zaman MM, Bhuiyan MR, Karim MN,
et al.
Clustering of non-
communicable diseases risk factors in Bangladeshi adults: An analysis
of STEPS survey 2013.
BMC Public Health
2015;
15
: 659. doi: 10.1186/
s12889-015-1938-4.
26. Aryeetey R, Ansong J. Overweight and hypertension among college of
health sciences employees in Ghana.
Afr J Food Agric Nutr Devt
2011;
11
(6): 5444–5456. doi: 10.4314/ajfand.v11i6.
27. Fawibe AE, Shittu AO. Prevalence and characteristics of cigarette smok-
ers among undergraduates of the University of Ilorin, Nigeria.
Niger J
Clin Pract
2011;
14
(2): 201–205. doi: 10.4103/1119-3077.84016.
28. Aryal KK, Mehata S, Neupane S,
et al
. The burden and determinants
of non communicable diseases risk factors in Nepal: Findings from a
nationwide STEPS survey.
PLoS One
2015;
10
(8): 1–18. doi: 10.1371/
journal.pone.0134834.
29. Zaborskis A, Sirvyte D. Familial determinants of current smoking
among adolescents of Lithuania: a cross-sectional survey 2014.
BMC
Public Health
2015;
15
(1): 889. doi: 10.1186/s12889-015-2230-3.
30. Crichton GE, Alkerwi A. Physical activity, sedentary behavior time
and lipid levels in the Observation of Cardiovascular Risk Factors in
Luxembourg study.
Lipids Health Dis
2015;
14
(1): 87. doi: 10.1186/
s12944-015-0085-3.
31. Daviglus ML, Talavera GA, Avilés-santa ML, Giachello AL, Gouskova
N, Kaplan RC.
NIH Public Access
2013;
308
(17): 1775–1784. doi:
10.1001/jama.2012.14517.Prevalence.
32. Phaswana-Mafuya N, Peltzer K, Chirinda W, Musekiwa A, Kose Z.
Sociodemographic predictors of multiple non-communicable disease
risk factors among older adults in South Africa.
Glob Health Action
2013;
6
(1): 1–8. doi: 10.3402/gha.v6i0.20680.
33. Truthmann J, Busch MA, Scheidt-Nave C,
et al
. Modifiable cardiovas-
cular risk factors in adults aged 40–79 years in Germany with and with-
out prior coronary heart disease or stroke.
BMC Public Health
2015;
15
(1): 701. doi: 10.1186/s12889-015-1929-5.
34. Wu F, Guo Y, Chatterji S,
et al
. Common risk factors for chronic non-
communicable diseases among older adults in China, Ghana, Mexico,
India, Russia and South Africa: the study on global AGEing and adult
health (SAGE) wave 1.
BMC Public Health
2015;
15
(1): 88. doi: 10.1186/
s12889-015-1407-0.
35. Seck SM, Guéye S, Tamba K, Ba I. Prevalence of chronic cardiovascular
and metabolic diseases in Senegalese workers: a cross-sectional study,
2010.
Prev Chronic Dis
2013;
10
(5): 110339. doi: 10.5888/pcd10.110339.
36. Villegas R, Kearney PM, Perry IJ. The cumulative effect of core lifestyle
behaviours on the prevalence of hypertension and dyslipidemia.
BMC
Public Health
2008;
8
(1): 210. doi: 10.1186/1471-2458-8-210.
37. Oluyombo R, Olamoyegun MA, Olaifa O, Iwuala SO, Babatunde OA.
Cardiovascular risk factors in semi-urban communities in southwest
Nigeria: Patterns and prevalence.
J Epidemiol Glob Health
2015;
5
(2):
167–174. doi: 10.1016/j.jegh.2014.07.002.
38. Msyamboza KP, Ngwira B, Dzowela T,
et al.
The burden of selected
chronic non-communicable diseases and their risk factors in malawi:
Nationwide steps survey.
PLoS One
2011;
6
(5): 6–11. doi: 10.1371/
journal.pone.0020316.
39. Ogna VF, Ogna A, Ponte B,
et al
. Prevalence and determinants of
chronic kidney disease in the Swiss population.
Swiss Med Wkly
2016;
146
: 14313. doi: 10.4414/smw.2016.14313.
40. Hallan SI, Coresh J, Astor BC,
et al
. International Comparison of the
relationship of chronic kidney disease prevalence and ESRD risk.
J Am
Soc Nephrol
2006;
17
(8): 2275–2284. doi: 10.1681/ASN.2005121273.
41. Ji E, Kim YS. Prevalence of chronic kidney disease defined by using
CKD-EPI equation and albumin-to-creatinine ratio in the Korean adult
population.
Korean J Intern Med
2016;
31
(6): 1120–1130.
42. Seck SM, Doupa D, Guéye L, Dia CA. Epidemiology of chronic kidney
disease in northern region of Senegal: A community-based study in 2012.
Pan Afr Med J
2014;
18
: 1–8. doi: 10.11604/pamj.2014.18.307.3636.
43. Kaze FF, Halle M-P, Mopa HT,
et al
. Prevalence and risk factors of
chronic kidney disease in urban adult Cameroonians according to three
common estimators of the glomerular filtration rate: a cross-sectional
study.
BMC Nephrol
2015;
16
(1): 96. doi: 10.1186/s12882-015-0102-9.
44. Egbi OG, Okafor UH, Miebodei KE, Kasia BE, Kunle-Olowu OE,
Unuigbe EI. Prevalence and correlates of chronic kidney disease among
civil servants in Bayelsa state, Nigeria.
Niger J Clin Pract
2014;
17
(5):
602–607. doi: 10.4103/1119-3077.141426.